Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
- Status
- UNKNOWN
- Phase
- PHASE2
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fenretinide in Treating Patients With Leukoplakia of the Mouth
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
- Status
- COMPLETED
- Phase
- PHASE2
High-dose ICE With Amifostine
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
- Status
- UNKNOWN
- Phase
- PHASE3